Dramatic improvement of pure red cell aplasia refractory to combined cyclosporine and prednisolone therapy induced by prednisolone dose escalation.
Nakao
S
S
Third Department of Internal Medicine, Kanazawa University School of Medicine, Japan.
Masaoka
H
H
Shiobara
S
S
Mori
T
T
Matsuda
T
T
D016572:Cyclosporine / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use*; D012010:Red-Cell Aplasia, Pure / Q000188:drug therapy*
D016572:Cyclosporine; D011239:Prednisolone